Brain Cancer
The company has previously offered its liquid biopsy tests through an LDT model but sees the timing and the clinical niche as right for a regulatory bid in CSF testing.
Berg Advances BPM31510, Applies AI Platform to Biomarker Search in Phase II Brain Cancer Trial
Premium
The firm will collect multi-omics data from GBM patients and use its AI platform to home in on biomarkers of response to BPM31510.
Datar Cancer Genetics Obtains CE Mark for Liquid Biopsy Cancer Test
The firm said its test can be used to evaluate blood samples from people who present with suspicious growths in the breast, lung, prostate, colon, or brain.
Glioblastoma Transcriptomes Point to Mitochondrial Subtype, Potential Treatment Strategies
Using single-cell and bulk RNA sequence data, investigators identified four pathway-based GBM subtypes, including a mitochondrial subtype that appears to respond to related inhibitors.
Bristol Myers Unblinds Trial After Opdivo, Chemoradiation Fail to Extend Survival in Glioblastoma
A data monitoring committee said that BMS's immunotherapy plus standard of care would not improve overall survival in MGMT-methylated brain cancer patients.